Physician

Gabor Menczelesz, MD

According to 2025 Medicare claims, Gabor Menczelesz, MD (NPI: 1609869833) practices internal medicine in the Deltona-Daytona Beach-Ormond Beach, FL market, with the plurality of this provider's patient population coming from Volusia, FL. This provider's primary affiliated billing organization is NOBLE INFUSION, LLC (NPI: 1346089513) and primary practice location at 32174-5276.

Menczelesz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 204 traditional Medicare patients, billed 10,317 HCPCS/CPT codes, and received $57,886 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 440 prescription claims across 182 beneficiaries totaling $36,624 in drug costs, led by Atorvastatin Calcium (Atorvastatin Calcium). DME data shows 55 claims. Open Payments data shows 3 records totaling $63. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $520,095 to $36,624. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$29K$58K2024 Medicare payment: $57,886 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202420410,317$57,886

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$260K$520K2015 Drug cost: $520,095 (USD; Tot_Drug_Cst)2016 Drug cost: $27,820 (USD; Tot_Drug_Cst)2017 Drug cost: $4,430 (USD; Tot_Drug_Cst)2018 Drug cost: $729 (USD; Tot_Drug_Cst)2019 Drug cost: $567 (USD; Tot_Drug_Cst)2020 Drug cost: $205 (USD; Tot_Drug_Cst)2021 Drug cost: $2,190 (USD; Tot_Drug_Cst)2022 Drug cost: $876 (USD; Tot_Drug_Cst)2023 Drug cost: $131,963 (USD; Tot_Drug_Cst)2024 Drug cost: $36,624 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151704,219$520,095
201692667$27,820
201730195$4,430
2018N/R82$729
2019N/R66$567
2020N/R12$205
20211431$2,190
2022N/R24$876
20232881,157$131,963
2024182440$36,624

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$34K$67K2015 Medicare payment: $901 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $194 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $67,439 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20153690$901
2016N/R22$194
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
20245555$67,439

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit134134$126
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1516$88
99497Advance care planning, first 30 minutes142142$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1920$67
G0442Annual alcohol misuse screening, 5 to 15 minutes2222$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Atorvastatin CalciumAtorvastatin Calcium332,978$350
Metoprolol SuccinateMetoprolol Succinate221,530$321
Losartan PotassiumLosartan Potassium221,990$301
OmeprazoleOmeprazole111,010$244
Rosuvastatin CalciumRosuvastatin Calcium12932$185

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
L0637Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertiseN3333$41,478
L1843Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertiseN1111$18,308
L3960Shoulder elbow wrist hand orthosis, abduction positioning, airplane design, prefabricated, includes fitting and adjustmentN1111$7,653

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$63Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gabor Menczelesz, MD?

Tedicare shows public-source Medicare data for Gabor Menczelesz, MD (NPI 1609869833), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gabor Menczelesz, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gabor Menczelesz, MD?

Gabor Menczelesz, MD is linked to NOBLE INFUSION, LLC (billing NPI 1346089513) in the available physician profile data.

Does Gabor Menczelesz, MD have Open Payments data?

Gabor Menczelesz, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.